A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 11, 2015

Primary Completion Date

September 17, 2018

Study Completion Date

September 17, 2018

Conditions
Ulcerative Colitis
Trial Locations (19)

16247

St. Vincent's Hospital /ID# 138455, Suwon

16499

Ajou University Hospital /ID# 138457, Suwon

22332

Inha University Hospital /ID# 150176, Junggu

41944

Kyungpook National Univ Hosp /ID# 153133, Daegu

47392

Inje University Busan Paik Hospital /ID# 138451, Pusan

61453

Chosun University Hospital /ID# 138454, Gwangju

61469

Chonnam National University Hospital /ID# 138450, Gwangju

02447

Kyung Hee University Medical Center /ID# 138453, Dongdaemun-gu

03181

Kangbuk Samsung Hospital /ID# 150175, Jongno-Gu

03722

Severance Hospital /ID# 138456, Seoul

06351

Samsung Medical Center /ID# 138449, Seoul

07061

SMG-SNU Boramae Medical Center /ID# 138448, Seoul

700-712

Keimyung Univ Dongsan medical /ID# 138447, Daegu

301-723

Daejeon St. Mary's Hospital /ID# 138445, Daejeon

02841

Korea University Anam Hospital /ID# 138446, Seoul

03080

Seoul National University Hospital /ID# 138443, Seoul

07985

Ewha Womans University Mokdong /ID# 138444, Seoul

100-032

Inje University Seoul Paik Hos /ID# 138452, Seoul

156-755

Chung-Ang University Med. Ctr. /ID# 138441, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY